Page 225 - எங்களுக்கு தேசிய நிறுவனம் ஆஃப் ஒவ்வாமை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

As hospitalizations and deaths from Covid-19 rise, governments are grappling with whether to prioritize getting a first shot of vaccine into as many arms as possible, or to take a slower approach that reserves some of the limited supply to deliver a second dose at the optimal interval to attain maximum protection. Some governments seem willing to accept the trade-off of lower immunity to inoculate more people. Some scientists have cautioned that untested timing regimens have the potential to und

United kingdomAnthony fauciBritish medical associationWorld health organizationAstrazeneca plcUs national institute of allergyPfizer incEuropean medicines agencyModerna incInfectious diseasesஒன்றுபட்டது கிஂக்டம்பிரிட்டிஷ் மருத்துவ சங்கம்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்எங்களுக்கு தேசிய நிறுவனம் ஆஃப் ஒவ்வாமைஃபைசர் இன்க்மாடர்னா இன்க்